Our Solutions
Where innovation meets
opportunity for patients in Europe.
We offer Biopharmaceutical companies committed to addressing unmet medical needs in rare and serious diseases flexible strategic partnerships for the direct commercialization of their first pharmaceutical product in Europe.
Achieving Successful European Market Entry.
Expanding into Europe to launch a first product requires significant resources and regional expertise. This can be particularly challenging for companies with limited or no initial presence in the EU.
Our tailored approach ensures efficient management of European market entry and product launches, leveraging Early Access Programs whenever possible.
We establish, oversee, and manage customized and appropriately scaled go-to-market organizations on behalf of our partners, ensuring a seamless transition from product development to market launch.
Our Solutions.
We provide innovative solutions to enter the EU market by maximizing flexibility and minimizing operational burden, from registration through to commercialization.
Expand to Europe
A unique partnership model that goes beyond traditional full outsourcing or licensing agreements.
Unlock an EU country
Unlock France
Flexible Turnkey solutions to swiftly establish your locally compliant organization, surpassing conventional models.
Early Access Program
A unique, all-in-one solution for launching an early access program in one of Europe's most supportive regulatory environments.